Skip to content

Bruno Bock acquires ipox chemicals

We are pleased to announce that Bruno Bock and ipox chemicals arrived to the final agreement under which Bruno Bock is acquiring ipox chemicals GmbH and its wholly owned Hungarian subsidiary ipox chemicals Kft. 

As part of the transaction the companies agreed to continue operation at the ipox sites in Laupheim and Budapest in addition to Bruno Bock´s sites in Marschacht and Waterloo. 

The acquisition marks an important milestone in Bruno Bock´s transformation to a specialty chemicals business. The complementary product portfolios strengthen the groups position in the Coatings, Adhesives and Sealants industry and “create” an innovative and highly specialized partner for customers globally. 

“We are extremely excited to have the ipox team join the Bruno Bock family” says Stefan Wickmann, CEO of Bruno Bock, “ipox represents an excellent, complementary addition to the Bruno Bock group.“  

The current management team of ipox will remain in charge and will continue to lead the business with their entrepreneurial mindset and market expertise. 

“We look forward to the continued support for our growth strategy from our new parent company and the excellent opportunities to enter new markets for our products” says Dr. Georg Göttle, Managing Director of ipox chemicals. “Bruno Bock brings exactly the right background to further expand the production of our specialties." 



Bruno Bock is the leading manufacturer of organosulfur specialty chemicals for the Personal & Home Care industry, the CASE Industry and other industrial applications. 

The Bruno Bock Group operates production facilities in Marschacht, Germany and Waterloo, USA and a sales office in Shanghai, China. 



ipox chemicals is the specialist in manufacturing highly customized epoxy formulations for the CASE industry, for technical fiber and 3D-printing applications. ipox chemicals serves its markets from its headquarters in Laupheim, Germany and its production site in Budapest, Hungary. 

  • For more details about this news, please contact us! We are looking forward to your message!